Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD4-positive, alpha-beta T cell | 5 studies | 27% ± 6% | |
CD8-positive, alpha-beta T cell | 5 studies | 27% ± 6% | |
non-classical monocyte | 5 studies | 30% ± 14% | |
plasmacytoid dendritic cell | 5 studies | 34% ± 13% | |
B cell | 4 studies | 18% ± 4% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 23% ± 3% | |
natural killer cell | 4 studies | 24% ± 6% | |
myeloid cell | 4 studies | 21% ± 7% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 28% ± 2% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 35% ± 10% | |
mucosal invariant T cell | 3 studies | 29% ± 9% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 22% ± 3% | |
dendritic cell | 3 studies | 32% ± 19% | |
macrophage | 3 studies | 22% ± 7% | |
oligodendrocyte | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2673.60 | 258 / 258 | 100% | 5.39 | 229 / 230 |
intestine | 100% | 3294.14 | 966 / 966 | 99% | 5.04 | 524 / 527 |
kidney | 100% | 2389.06 | 89 / 89 | 99% | 4.45 | 893 / 901 |
brain | 99% | 2453.27 | 2616 / 2642 | 100% | 8.29 | 705 / 705 |
uterus | 100% | 1958.11 | 170 / 170 | 99% | 4.14 | 453 / 459 |
bladder | 100% | 2079.00 | 21 / 21 | 99% | 4.65 | 497 / 504 |
thymus | 100% | 2567.49 | 652 / 653 | 99% | 3.80 | 597 / 605 |
stomach | 100% | 1912.98 | 359 / 359 | 98% | 4.20 | 281 / 286 |
prostate | 100% | 2590.50 | 244 / 245 | 99% | 2.44 | 495 / 502 |
lung | 100% | 4785.80 | 577 / 578 | 98% | 3.48 | 1135 / 1155 |
breast | 100% | 2309.67 | 459 / 459 | 98% | 3.65 | 1096 / 1118 |
esophagus | 100% | 1881.15 | 1440 / 1445 | 97% | 2.67 | 177 / 183 |
skin | 95% | 1551.56 | 1719 / 1809 | 99% | 5.79 | 469 / 472 |
pancreas | 90% | 1049.60 | 295 / 328 | 99% | 5.13 | 177 / 178 |
ovary | 94% | 1142.44 | 169 / 180 | 88% | 1.80 | 377 / 430 |
liver | 71% | 705.45 | 160 / 226 | 86% | 2.39 | 350 / 406 |
adipose | 100% | 2511.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.94 | 29 / 29 |
peripheral blood | 100% | 9392.26 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 10132.63 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.12 | 1 / 1 |
blood vessel | 99% | 2079.33 | 1327 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 3.73 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 98% | 4.60 | 78 / 80 |
heart | 94% | 1119.16 | 809 / 861 | 0% | 0 | 0 / 0 |
muscle | 58% | 479.71 | 465 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030010 | Biological process | establishment of cell polarity |
GO_0035332 | Biological process | positive regulation of hippo signaling |
GO_0015031 | Biological process | protein transport |
GO_0030041 | Biological process | actin filament polymerization |
GO_0007030 | Biological process | Golgi organization |
GO_0016477 | Biological process | cell migration |
GO_0006895 | Biological process | Golgi to endosome transport |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | CORO7 |
Protein name | Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog) Coronin-7 Coronin |
Synonyms | |
Description | FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . FUNCTION: F-actin regulator involved in anterograde Golgi to endosome transport: upon ubiquitination via 'Lys-33'-linked ubiquitin chains by the BCR(KLHL20) E3 ubiquitin ligase complex, interacts with EPS15 and localizes to the trans-Golgi network, where it promotes actin polymerization, thereby facilitating post-Golgi trafficking. May play a role in the maintenance of the Golgi apparatus morphology. . |
Accessions | ENST00000572153.5 P57737 ENST00000575850.5 ENST00000572898.1 ENST00000631578.1 ENST00000633889.1 ENST00000614702.4 [P57737-1] I3L0X8 I3L1T5 I3L212 ENST00000631678.1 ENST00000632603.1 ENST00000631757.1 I3L359 ENST00000570645.5 ENST00000573165.1 ENST00000632167.1 ENST00000632164.1 ENST00000631809.1 ENST00000574025.5 [P57737-2] I3L1G9 ENST00000576637.1 ENST00000572044.1 I3L1M1 ENST00000617235.2 [P57737-4] ENST00000631534.1 [P57737-2] ENST00000632177.1 ENST00000251166.9 [P57737-1] ENST00000576051.5 I3L482 ENST00000574311.5 I3L351 ENST00000634048.1 E7EP81 I3L2Y6 ENST00000633467.1 I3L0Z7 ENST00000571756.5 ENST00000570779.1 I3L258 ENST00000576437.5 I3L442 ENST00000571052.5 I3L426 I3NI06 ENST00000572549.5 ENST00000571227.5 ENST00000633681.1 I3L2S7 ENST00000632515.1 ENST00000570928.5 ENST00000537233.6 [P57737-4] ENST00000633070.1 I3L1Z1 ENST00000632270.1 ENST00000575038.5 ENST00000631960.1 ENST00000571059.5 ENST00000632158.1 I3L423 ENST00000633804.1 |